BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11416759)

  • 21. Comparative studies on the expression of somatostatin receptor subtypes, outcome of octreotide scintigraphy and response to octreotide treatment in patients with carcinoid tumours.
    Nilsson O; Kölby L; Wängberg B; Wigander A; Billig H; William-Olsson L; Fjälling M; Forssell-Aronsson E; Ahlman H
    Br J Cancer; 1998 Feb; 77(4):632-7. PubMed ID: 9484822
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A "false positive" octreoscan in ileal Crohn's disease.
    Fernandez A; Tabuenca O; Peteiro A
    World J Gastroenterol; 2008 Sep; 14(34):5349-52. PubMed ID: 18785291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gastrointestinal: An unusual cause of lower gastrointestinal bleed: Ileal carcinoid tumor.
    Mallick B; Nath P; Praharaj DL; Biswal SK; Panigrahi SC; Anand AC
    J Gastroenterol Hepatol; 2020 Mar; 35(3):359. PubMed ID: 31786821
    [No Abstract]   [Full Text] [Related]  

  • 24. [Use of 111-in octreotide in the evaluation of the secondary pathology by carcinoid tumor].
    Lopes AF; Cavicchioli M; Lima EN; Chojniak R
    Rev Assoc Med Bras (1992); 2006; 52(5):292. PubMed ID: 17160299
    [No Abstract]   [Full Text] [Related]  

  • 25. Detection of a carcinoid tumor by the radionuclide method.
    Crasset V; Delcourt E; Dekoninck W
    Clin Nucl Med; 1994 Oct; 19(10):919. PubMed ID: 7805335
    [No Abstract]   [Full Text] [Related]  

  • 26. [Somatostatin receptor scintigraphy in pediatric bronchial carcinoid tumor].
    Hervás Benito I; Bello Arques P; Loaiza JL; Vercher JL; Velasco RP; Rivas Sánchez A; Ruiz Llorca C; Martí Vidal JF; Mateo Navarro A
    Rev Esp Med Nucl; 2010; 29(1):25-8. PubMed ID: 19819594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recurrent ectopic adrenocorticotropic hormone producing thymic carcinoid detected with octreotide imaging.
    Silva F; Vázquez-Sellés J; Aguilö F; Vázquez G; Flores C
    Clin Nucl Med; 1999 Feb; 24(2):109-10. PubMed ID: 9988068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Carcinoid of the proximal ileum].
    Marín-López E; Rojas Ortega S; Sánchez Sosa S
    Rev Gastroenterol Mex; 1994; 59(3):227. PubMed ID: 7716364
    [No Abstract]   [Full Text] [Related]  

  • 29. False-negative fluorine-18-FDG PET in metastatic carcinoid.
    Jadvar H; Segall GM
    J Nucl Med; 1997 Sep; 38(9):1382-3. PubMed ID: 9293792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Terminal ileal carcinoid tumor without hepatic or extrahepatic metastasis causing carcinoid syndrome.
    Datta J; Merchant NB
    Am Surg; 2013 Apr; 79(4):439-41. PubMed ID: 23574858
    [No Abstract]   [Full Text] [Related]  

  • 31. Metastatic renal carcinoid: case report and review of the literature.
    Tal R; Lask DM; Livne PM
    Urology; 2003 Apr; 61(4):838. PubMed ID: 12670585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metastatic carcinoid tumor imaged with CT and a radiolabeled somatostatin analog: a case report.
    Lobrano MB; McCarthy K; Adams L; Neitzschman H
    Am J Gastroenterol; 1997 Mar; 92(3):513-5. PubMed ID: 9068482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary ovarian carcinoid: value of octreotide scintigraphy for diagnosis and correlation with other cross-sectional imaging modalities and pathology.
    Trapanotto V; Hamper UM; Gordon A; Krasner AS; Civelek AC
    J Ultrasound Med; 1997 Jul; 16(7):505-8. PubMed ID: 9315203
    [No Abstract]   [Full Text] [Related]  

  • 34. Unknown multifocal ileal carcinoid revealed by (18)F-FDOPA PET/CT.
    Imperiale A; Averous G; Chilinseva-Natorov N; Hubelé F; Triki E; Bellocq JP; Namer IJ; Brigand C
    J Clin Endocrinol Metab; 2014 May; 99(5):1510-1. PubMed ID: 24606103
    [No Abstract]   [Full Text] [Related]  

  • 35. [Thoracic SPECT using (111 In-DTPA-D-Phe1)-octreotide in bronchial carcinoid syndrome].
    Banzo J; Sebastián A; Prats E; Freile E; García F; Costán J; Razola P; Tomás A; Cegoñino J; Abós MD
    Rev Esp Med Nucl; 1998; 17(1):45-8. PubMed ID: 9609844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Localisation of carcinoid tumour with radiolabelled octreotide and intraoperative gamma detection.
    Dominioni L; Dionigi R; Benevento A; Garancini S; Roncari G
    Lancet; 1994 Dec 24-31; 344(8939-8940):1783. PubMed ID: 7997041
    [No Abstract]   [Full Text] [Related]  

  • 37. Vasoactive intestinal peptide and somatostatin receptor scintigraphy for differential diagnosis of hepatic carcinoid metastasis.
    Kurtaran A; Raderer M; Müller C; Prokesch R; Kaserer K; Eibenberger K; Koperna K; Niederle B; Virgolini I
    J Nucl Med; 1997 Jun; 38(6):880-1. PubMed ID: 9189133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Residents' corner. Answer to case of the month #52. Carcinoid tumour of the small bowel.
    Zander DR; Rosenbloom M; Bégin LR
    Can Assoc Radiol J; 1998 Feb; 49(1):49-51. PubMed ID: 9494465
    [No Abstract]   [Full Text] [Related]  

  • 39. In-111 octreotide scan in a case of a neuroendocrine tumor of unknown origin.
    Fuster D; Navasa M; Pons F; Vidal-Sicart S; Mateos JJ; Lomeña F; Rodes J; Herranz R
    Clin Nucl Med; 1999 Dec; 24(12):955-8. PubMed ID: 10595476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of labeled MIBG and somatostatin analogs in imaging neuroendocrine tumors.
    Lastoria S; Maurea S; Vergara E; Acampa W; Varrella P; Klain M; Muto P; Bernardy JD; Salvatore M
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):145-9. PubMed ID: 9002775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.